BIOTRICITY INC.
BIOTRICITY INC.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 0 | |||||
Assets Current | |||||||||||||||||
Assets Current | 6 | 5 | 6 | 5 | 5 | 5 | 4 | 4 | 4 | 4 | 5 | 4 | |||||
Accounts Receivable Net Current | 3 | 2 | 2 | 2 | 2 | 1 | 1 | 2 | 1 | 2 | 2 | 2 | |||||
Inventory Net | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Deposits Assets Current | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 0 | 0 | 0 | 1 | |||||
Deposits Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Accounts Receivable Net Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Right Of Use Asset | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Assets | 6 | 6 | 6 | 6 | 6 | 6 | 5 | 5 | 6 | 5 | 7 | 6 | |||||
Accounts Payable And Accrued Liabilities Current | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 8 | 10 | 8 | 7 | 7 | |||||
Liabilities Current | |||||||||||||||||
Liabilities Current | 37 | 24 | 24 | 22 | 21 | 21 | 21 | 21 | 23 | 19 | 18 | 15 | |||||
Convertible Notes Payable Current | 11 | 11 | 10 | 10 | 10 | 9 | 8 | 8 | 9 | 8 | 7 | 6 | |||||
Loans Payable To Bank Current | 15 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 2 | 2 | 1 | - | |||||
Derivative Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 3 | 2 | |||||
Operating Lease Liability Current | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Other Loans Payable Long Term | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Long Term Loans From Bank | - | 12 | 12 | 12 | 12 | 12 | 9 | 9 | 10 | 11 | 11 | 12 | |||||
Derivative Liabilities Noncurrent | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | |||||
Operating Lease Liability Noncurrent | - | - | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Liabilities | 39 | 38 | 38 | 37 | 36 | 36 | 34 | 33 | 36 | 32 | 32 | 30 | |||||
Temporary Equity | |||||||||||||||||
Temporary Equity Carrying Amount Attributable To P… | 2 | 2 | - | - | 2 | 2 | 2 | - | - | - | - | - | |||||
Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 108 | 108 | 107 | 107 | 107 | 105 | 105 | 104 | 96 | 96 | 93 | 93 | |||||
Stockholders Equity | |||||||||||||||||
Stockholders Equity | -35 | -34 | -33 | -33 | -32 | -32 | -31 | -30 | -31 | -28 | -27 | -23 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -0 | -0 | -0 | 0 | 0 | 0 | -0 | 0 | 0 | -0 | -0 | -0 | |||||
Retained Earnings Accumulated Deficit | -143 | -142 | -141 | -140 | -139 | -137 | -139 | -139 | -127 | -123 | -120 | -116 | |||||
Liabilities And Stockholders Equity | 6 | 6 | 6 | 6 | 6 | 6 | 5 | 5 | 6 | 5 | 7 | 6 | |||||
Preferred Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 125 | 125 | 125 | 125 | 125 | 125 | 125 | 125 | 125 | 125 | 125 | 125 | |||||
Common Stock Shares Issued | 86 | 83 | 80 | 80 | 78 | 73 | 69 | 64 | 56 | 56 | 51 | 51 | |||||
Shares Outstanding | 29 | 28 | 27 | 27 | 26 | 24 | 23 | 21 | 9 | 9 | 9 | 9 | |||||
Common Stock Other Shares Outstanding | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 27.78% | -4.62% | 5.54% | -14.31% | -47.53% | -49.23% | -4.17% | -1.87% | 9.50% | - | - | - |
| 2025 | -5.12% | -39.00% | -17.07% | -29.29% | -12.50% | -2.77% | -24.11% | -36.49% | -22.73% | 7.60% | 68.28% | 25.62% |
| 2024 | -14.05% | -14.05% | -59.38% | 20.01% | 30.01% | -0.71% | 9.09% | -1.99% | 4.41% | -11.11% | -56.69% | -58.04% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 0.16 | 0.21 | 0.23 | 0.24 | 0.22 | 0.23 | 0.19 | 0.20 | 0.20 | 0.21 | 0.29 | 0.29 | |||||
| Quick Ratio | 0.12 | 0.13 | 0.14 | 0.15 | 0.15 | 0.16 | 0.10 | 0.11 | 0.11 | 0.10 | 0.17 | 0.14 | |||||
| Working Capital | -31.28M | -18.82M | -18.08M | -16.66M | -16.00M | -16.28M | -17.42M | -16.49M | -18.23M | -14.69M | -12.65M | -10.70M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | -1.14 | -1.12 | -1.14 | -1.12 | -1.11 | -1.12 | -1.10 | -1.11 | -1.14 | -1.16 | -1.21 | -1.26 | |||||
| Interest Coverage TTM | 0.50 | 0.04 | -0.14 | -0.31 | -0.75 | -1.46 | -1.84 | -2.44 | -2.92 | -3.26 | -4.79 | -6.46 | |||||
| Debt Ratio | 6.11 | 6.72 | 6.01 | 6.10 | 6.32 | 5.98 | 6.46 | 6.09 | 6.04 | 5.87 | 4.73 | 4.81 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 2.65 | 2.65 | 2.60 | 2.52 | 2.38 | 2.31 | 2.08 | 2.12 | 1.94 | 1.92 | 1.49 | 1.16 | |||||
| Days Sales Outstanding TTM | 52.38 | 33.24 | 43.55 | 42.63 | 41.39 | 38.65 | 44.98 | 45.17 | 40.74 | 55.70 | 59.43 | 57.48 | |||||
| Receivables Turnover TTM | 6.97 | 10.98 | 8.38 | 8.56 | 8.82 | 9.44 | 8.12 | 8.08 | 8.96 | 6.55 | 6.14 | 6.35 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.09 | -0.31 | -0.30 | -0.34 | -0.55 | -0.52 | -0.53 | -1.00 | -1.57 | -1.75 | -1.87 | -1.97 | |||||
| Free Cash Flow Per Share TTM | -0.03 | -0.04 | -0.02 | -0.05 | -0.11 | -0.13 | -0.19 | -0.45 | -0.74 | -0.82 | -1.06 | -1.30 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.11 | 0.11 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 80.94% | 81.09% | 79.84% | 78.26% | 76.61% | 74.31% | 73.40% | 71.89% | 69.27% | 65.52% | 61.66% | 57.84% | |||||
| Operating Profit Margin TTM | 10.57% | 0.91% | -3.11% | -7.26% | -17.76% | -34.96% | -45.57% | -62.30% | -73.18% | -79.45% | -106.12% | -128.61% | |||||
| Net Profit Margin TTM | -15.03% | -56.04% | -52.76% | -61.67% | -86.60% | -94.97% | -94.76% | -115.87% | -116.84% | -135.17% | -147.78% | -162.54% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 16.01% | 16.46% | 19.51% | 18.12% | 14.32% | 14.09% | 13.55% | 15.47% | 25.15% | 28.55% | 30.50% | 33.51% | |||||
| Net Income Growth (1Y) | -79.87% | -31.28% | -33.46% | -37.13% | -15.27% | -19.84% | -27.19% | -17.69% | -24.46% | -58.72% | -52.85% | -58.11% | |||||
| EPS Growth (1Y) | -84.13% | -39.64% | -44.09% | -66.11% | -64.61% | -70.30% | -71.53% | -49.15% | -27.25% | -60.05% | -53.67% | -58.96% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -2.68 | -0.96 | -1.78 | -1.09 | -0.61 | -0.56 | -0.44 | -0.90 | -0.94 | -0.66 | -1.15 | -1.94 | |||||
| P/B TTM | -0.19 | -0.24 | -0.42 | -0.30 | -0.23 | -0.22 | -0.17 | -0.43 | -0.42 | -0.37 | -0.70 | -1.43 | |||||
| P/S TTM | 0.40 | 0.54 | 0.94 | 0.67 | 0.53 | 0.53 | 0.42 | 1.04 | 1.10 | 0.89 | 1.69 | 3.16 | |||||
| Market Cap | 6.44M | 8.28M | 14.19M | 9.73M | 7.32M | 7.02M | 5.29M | 12.75M | 13.31M | 10.33M | 18.82M | 33.48M | |||||
| Enterprise Value | 17.41M | 19.17M | 24.27M | 19.43M | 16.57M | 15.92M | 13.59M | 21.15M | 21.76M | 18.16M | 24.34M | 39.03M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -718.96K | -1.10M | -446.64K | -1.26M | -2.38M | -3.15M | -4.36M | -6.36M | -6.69M | -7.41M | -9.28M | -11.34M | |||||
| Net Debt | 10.96M | 10.89M | 10.09M | 9.69M | 9.25M | 8.90M | 8.31M | 8.40M | 8.45M | 7.84M | 5.52M | 5.55M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
BIOTRICITY INC. (BTCY) — SEC Financial Statements & Analysis
BIOTRICITY INC. (BTCY) is a surgical & medical instruments & apparatus company, incorporated in NV. BIOTRICITY INC. trades on OTC as: BTCY. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), BIOTRICITY INC. reported a 16.01% year-over-year revenue growth, a Gross Profit Margin of 80.94% (TTM), a Debt-to-Equity ratio of -1.14x, a Price-to-Sales (P/S) ratio of 0.40x (TTM), a Price-to-Book (P/B) ratio of -0.19 (TTM), at a market cap of $6.44M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 16.01%
- Gross Profit Margin TTM
- 80.94%
- Debt To Equity
- -1.14x
- P/S TTM
- 0.40x
- P/B TTM
- -0.19
- Market Cap
- $6.44M
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is BIOTRICITY INC. in?
BIOTRICITY INC. (BTCY) operates in the Surgical & Medical Instruments & Apparatus industry.
What is BTCY's market cap?
BIOTRICITY INC. (BTCY) has a market capitalization of $6.44M as of 2026-03-31.
What exchange does BTCY trade on?
BIOTRICITY INC. (BTCY) trades on the OTC.
Where is BIOTRICITY INC. incorporated?
BIOTRICITY INC. is incorporated in NV.